Stroke is caused by an interruption of the blood supply to a part of brain by thrombus or embolus occlusion or hemorrhage due to bursting of blood vessel and spilling blood into the spaces surrounding brain cells in all or part of the brain.
A Review On Mechanism Of Ischemic Brain Injury
Stroke is caused by an interruption of the blood supply to a part of brain by thrombus or embolus occlusion or hemorrhage due to bursting of blood vessel and spilling blood into the spaces surrounding brain cells in all or part of the brain. Symptoms of stroke are numbness of the face, arm, or leg, especially on one side of the body, confusion, trouble in speaking, seeing and walking, dizziness, loss of balance or coordination. severe headache. There are many types of stroke
A. Ischemic stroke
An ischemic stroke occurs when a blood vessel that supplies blood to the brain becomes blocked or clogged and impairs blood flow to part of the brain. Brain cells and tissues begin to die due to lack of oxygen and nutrients. The symptoms depend on the side of the brain affected, part of the brain, and how severely the brain is injured. Ischemic strokes are further divided into two groups:
a. Thrombotic stroke
Thrombotic stroke is caused by a thrombus (blood clot) that develops in an artery supplying blood to the brain. Thrombus formation occurs because of a fatty deposits, calcium and clotting factors such as fibrinogen and cholesterol, carried in the blood. This type of stroke is usually seen in older persons.
Large vessel thrombosis occurs in the brain’s larger artery and caused by combination of long-term atherosclerosis followed by rapid blood clot formation.
Small vessel disease or lacunar infarction occurs when blood flow is blocked to a very small arterial vessel and caused by high blood pressure.
b. Embolic stroke
In embolic stroke, the clots form outside of the brain (usually in the heart or large arteries of the upper chest and neck) and is transported through the bloodstream to the small blood vessel of brain and block its passage.
Embolic strokes result from heart disease or heart surgery and may be occur without any warning signs. In 15 percent of people with Embolic strokes, emboli are caused by Atrial fibrillation—an abnormal, rapid heartbeat in which the two atria of the heart quiver instead of beating. Quivers cause the blood to pool, forming clots.
B. Transient ischemic stroke (TIA)
Transient ischemic attack or mini-stroke are conditions indicative of an ischemic stroke. The obstruction occurs for a short time and tends to resolve itself through normal mechanisms. Even though the symptoms disappear after a short time, it is a strong indicator of a possible major stroke. Symptoms of a TIA are like ischemic stroke symptoms but do not last as long. Most symptoms disappear within an hour, although some may persist for up to 24 hours. Usually, no permanent brain damage occurs as a result of a TIA.
C. Hemorrhagic stroke
Hemorrhagic stroke occurs when a blood vessel in the brain suddenly ruptures and blood begins to leak directly into brain tissue and/or into the clear cerebrospinal fluid that surrounds the brain and fills its central cavities (ventricles). The rupture can be caused by long standing high blood pressure and cerebral aneurysm (a weak spot in a blood vessel wall usually present at birth) or other blood vessel malformation in or around the brain. Severity of the stroke depends on location of the hemorrhage rather than the amount of bleeding. Four types of hemorrhagic stroke
a. Subarachnoid hemorrhage
Subarachnoid hemorrhage occurs when bleeding from a damaged vessel causes blood to accumulate between the brain and the skull. When blood enters the subarachnoid space, it mixes with the cerebrospinal fluid (CSF) that cushions the brain and spinal cord and can block CSF circulation, which leads to fluid buildup and increased pressure on the brain. ventricles in the brain may enlarge resulting hydrocephalus.
Subarachnoid hemorrhage occurs because a cerebral aneurysm (an abnormal bulging outward in the wall of an artery), arteriovenous malformations (AVMs) and arteriovenous fistulas (AVFs) (abnormal connections between cerebral arteries) near the surface of the brain.
b. Intracerebral hemorrhage,
Intracerebral hemorrhage caused by the sudden rupture of an artery or blood vessel within the brain. The blood that leaks into the brain increase in pressure that can damage the surrounding brain cells. Sudden and extreme buildup in pressure can lead to unconsciousness or death.
Intracerebral hemorrhage is usually caused by hypertension, arteriovenous malformations (AVMs) and arteriovenous fistulas (AVFs) in the brain.
c. Subdural hematoma
Subdural hematoma develops in the potential space between the dura and the middle layer membrane (arachnoid). This condition may become chronic when shrinkage (atrophy) of the brain allows the brain to move more freely within the skull. High velocity impact to the skull may cause acute subdural hematoma, which is often fatal. This is often seen in elderly patients.
d. Epidural hemorrhage
Epidural hematoma develops in the potential space between the outer membrane (dura) and the skull.
2. Risk Factors
2.1. Risk Factors That Can Be Treated
•High blood pressure (hypertension) is the most important risk factor for stroke.
•Heart disease such as coronary artery disease, damaged heart valves, heart rhythm problems increase the risk of stroke as compare to healthy heart.
•Atherosclerosis called "hardening of the arteries” because build up of fatty materials, cholesterol, and calcium on the inside walls of the arteries block the vessels and increase the risk of stroke.
•High red blood cell count thickens the blood, leading to blood clots.
•Transient ischemic attacks (TIAs) usually happen when a blood clot temporarily blocks an artery in the brain or neck. TIAs are a warning sign of a possible stroke.
2.2.Risk Factors That Cannot Be Changed
•Age: The risk of stroke increases with age. From age 55 onward, chances of having a stroke more than double every ten years.
•Gender: The incidence of stroke is about 19% higher for men than for women..
•Race: According to the American Heart Association, African Americans have a higher risk of stroke than Caucasians.
•Diabetes: can be controlled; people with the disease are still more likely to have a stroke. If blood sugar is high, brain damage at the time of a stroke may be more severe and widespread.
•Heredity: The risk of stroke is greater in people who have a family history of stroke and TIAs.
•Carotid bruit: A bruit is an abnormal sound heard when a stethoscope is placed over a blocked artery, in this case the carotid artery. A carotid bruit most often means an increased risk for stroke.
•Carotid artery disease: Fatty deposits found in the carotid artery could block blood supply.
2.3. Contributing Risk Factors
•Smoking and Heavy alcohol use: According to the National Stroke Association, smoking and alcohol use doubles the risk for stroke.
•Physical inactivity: Inactivity is not only a major risk factor for developing coronary artery disease, but it can also lead to high blood pressure, low levels of high-density lipoproteins and diabetes.
•Obesity. According to the National Institute of Diabetes and Digestive and Kidney Disease, obesity doubles the risk for developing high blood pressure, a major risk factor for stroke.
•Birth control pills (oral contraceptives) alone are a low-level risk factor. But if birth control pills are combined with certain other risk factors such as smoking, the risk of stroke increases.
3. Ischemic Penumbra
Within the ischemic cerebrovascular bed, there are two major zones of injury: the core ischemic zone and the "ischemic penumbra"
In the core zone, which is an area of severe ischemia (blood flow below 10% to 25%), the loss of inadequate supply of oxygen and glucose results in rapid depletion of energy stores. Severe ischemia can result in necrosis of neurons and also of supporting cellular elements (glial cells) within the severely ischemic area.
Brain cells within the penumbra, a rim of mild to moderately ischemic tissue lying between tissue that is normally perfused and the area in which infarction is evolving, may remain viable for several hours. That is because the penumbral zone is supplied with blood by collateral arteries anastomosing with branches of the occluded vascular tree (see inset). However, even cells in this region will die if reperfusion is not established during the early hours since collateral circulation is inadequate to maintain the neuronal demand for oxygen and glucose indefinitely.
4. Mechanism of Ischemic brain injury
Figure 1: Mechanism of ischemic brain injury
Brain requires a continuous and steady flow of glucose and oxygen to undergo oxidative phosphorylation for energy production because brain has no store of energy and deprivation occur in minutes only (Durukan & Tatlisumak., 2007). Normal cerebral blood flow (CBF) is typically in the range of 45-50 ml/min/100g. (Dearden, 1985). When CBF falls to < 7 ml/min/100g irreversible cellular damage occur. The ischemic core is surrounded by region of moderate ischemic zone called ischemic penumbra (IP) with a CBF ranging from 7 to 17 ml/min/100g (Baron, 1999), which remains metabolically active but electrically silent (Astrup et al., 1981).
Decline in cerebral blood flow causes a number of important cellular changes. These include impaired energy metabolism, a measurable decrease in ATP production, increase in intracellular calcium level, loss of ion homeostasis, excitotoxicity, activation of enzyme such as nitric oxide synthatase, cyclooxygenase, phospholipase A2, protein kinase C, massive production of ROS, BBB disruption, edema and apoptosis (Chan, 2001).
4.1. Energy failure
The first consequence of CBF reduction is the depletion of substrate, particularly oxygen and glucose that causes loss of aerobic glycolysis and anaerobic glycolysis supervenes. Anaerobic glycolysis produces much less ATP per molecule of glucose and yields an excess amount of lactic acid. Excess amount of lactic acid induce temporary opening of Ca2+ conduction channel resulting large and sustain increase in neuronal Ca2+. (Nedergaard, 1995). Less ATP production leads to perturbation of the Na+/K+-ATPase, and Ca2+/H+-ATPase pumps and reversal of Na+-Ca2+ transporter (Phan et al., 2002) resulting elevation of intracellular Na+, Ca2+, Cl- and extracellular K+ levels. Increase intracellular Na+ causes rapid influx of water from extravascular compartment into cell produce edema called cytotoxic edema.
4.2. Glutamate mediated excitotoxicity
Calcium present extracellularly at a concentration 10,000 times greater than the intracellularly. With the energy depletion, membrane potential is lost and consequently neurons and glia depolarize (Dirnagl et al., 1999). After depolarization, large amount of glutamate are released into the extracellular compartment from presynaptic neurons. Glutamate activates NMDA, AMPA, and Metabotropic glutamate receptors. The channel within the NMDA receptor is blocked in a voltage-dependent manner by magnesium ion (Mg2+), which is dislodged by depolarization induced by activation of AMPA receptor (Nowak et al., 1984). NMDA receptor is the predominant route of Ca2+ flux during glutamatergic transmission. AMPA and kainite receptors are generally involved in Na+ conductance. Besides ionotropic receptor, glutamate also stimulates a family of metabotropic receptors that activate second messenger pathway resulting in the release of Ca2+.
The elevation in Ca2+ initiate a series of pathobiochemical processes such as activation of proteases, lipases, phospholipases, protein kinases, cyclooxygenase, synthase, calpain, and endonucleases, xanthine oxidase, calcium dependent nitric oxide synthase, leading to the breakdown of the cell membrane, cytoskeleton and the genomic DNA that lead to neuronal degeneration (Dirnagl et al., 1999).
As a consequence of phospholipase activation, the production of free fatty acids (FFA's) including the potent prostaglandin inducer, arachidonic acid (AA). The degradation of the membrane by phospholipases almost certainly damages membrane integrity, further reducing the efficiency of calcium pumping and leading to further calcium overload and a failure to regulate intracellular calcium levels (Farber et al., 1981). The production of AA as a result of FFA release causes the production of thromboxane and leukotrienes. Both these compounds are profound tissue irritants, which can cause platelet aggregation, clotting, vasospasm, and edema ( McIlvoy, 2005).
An influx of Ca2+ through NMDA receptors may lead to the activation of nNOS and the release of NO. Release of NO further leads to the formation of superoxide (O2 -), peroxynitrite (ONOO-) and hydroxyl (OH•) radicals (Beckman et al., 1990). ONOO- causes mitochondrial dysfunction during severe hypoxia–ischemia results in increased generation of oxygen free radicals leading to prompt dysfunction of cellular membrane causing necrosis.
Cellular injury within the penumbral region occur from recurrent waves of depolarization called spreading depression wave originate at the interface between ischemic core and penumbra. Spreading depression consumes energy and increases infarct volume. (Hartings et al., 2003). The most likely source for these spreading depression wave is the elevated extracellular K+ level and increase in the glutamate release at the boundaries between the ischemic core and the penumbra (Dijkhuizen et al., 1999).
4.3. Oxidative stress
During ischemia, the hydrolysis of ATP to AMP leads to an accumulation of hypoxanthine (Tien & Aust., 1982). Increased intracellular calcium enhances the conversion of xanthine dehydrogenase to xanthine oxidase . After reperfusion and reintroduction of oxygen, Xanthine oxidase may produce xanthine and superoxide from Hypoxanthine and oxygen (Lo et al., 2003;). Oxygen radicals are also produced during enzymatic conversions, such as the cyclooxygenase-dependent conversion of arachidonic acid to prostanoids (Lo et al., 2003). Under ischemic conditions, formation of mitochondrial permeability transition pore occurs and leads to a burst of free oxygen radicals and the release of proapoptotic molecules (Mergenthaler et al., 2004).
Reactive oxygen species react irreversibly with several cellular constituents such as proteins, double bonds of phospholipids, and nuclear DNA and cause lipid peroxidation, membrane damage, dysregulation of cellular processes, and mutations of the genome. Cell damage causes aberrations in ion homeostasis, cell signaling, and gene expression. Oxygen radicals serve as important signaling molecules that trigger inflammation and apoptosis (Dirnagl et al., 1999).
4.4. BBB disruption
BBB disruption occurs due to mechanical or hypoxic damage of vascular endothelium, toxic damage of inflammatory molecules and free radicals and mainly due to destruction of the basal lamina by matrix metalloproteinases which leads to vasogenic edema, influx of toxic substances, inflammation and presumably hemorrhagic complications. (Gartshore et al., 1997)
4.5. Inflammatory reactions
Inflammatory events, which are initiated at the blood micro vessel interface few hours after the onset of ischemia, underlie the transition from ischemic to inflammatory injury. Major players in the inflammatory injury are cytokines (IL-1, IL-6, TNF-α, and TGF-β), adhesion molecules (selectins, integrins, and immunoglobulins), eicasanoids and inducible neuronal nitric oxide synthase (iNOS), which are produced immediately after the onset of ischemia and contribute to irreversible damage. These molecules are produced by endothelial cells, astrocytes, microglial cells and leukocytes (granulocytes, monocyte/macrophages, lymphocytes).
Cell adhesion molecules including selectins, integrins and proteins of immunoglobulin gene family mediate cell to cell interaction for leukocyte migration. Selectins get upregulated in endothelial cells and leukocytes after focal cerebral ischemia and reperfusion (Huang et al., 2000). This polymorphonuclear (PMN) leukocyte get accumulated in the microvessels of penumbral region, leads to additional disruption of microcirculation and subsequent brain injury. Adhesion molecules of immunoglobulin gene family (intracellular adhesion molecule-1 and -2 (ICAM-1 and -2) and vascular cell adhesion molecule-1 (VCAM-1)) promote leukocyte adhesion to endothelial cells. (Soriano et al., 1996).
Similarly, cytokines such as IL-1, IL-6 and TNF-α are also important mediators of the inflammatory reactions in cerebral ischemia (del Zoppo et al., 2000). IL-1 induce release of arachidonic acid, enhancement of NMDA excitotoxicity and stimulation of nitric oxide synthase (Huang et al., 2006) and TNF-α induce the expression of adhesion molecules, which promotes leukocyte adherence and accumulation.
In addition, iNOS and cyclooxygenase-2 (COX-2) have been also suggested to play important role in inflammation through production of oxygen free radicals and prostanoids (Yokota et al., 2004).
Most brain lesions that develop after cerebral ischemia due to reduction of CBF evolve from an initial stage of reversible to an infarct or an area where most neurons become necrotic and then spread towards periphery of occluded artery (Garcia et al., 1995). Necrosis occurs due to loss of osmotic homeostasis in response to physiological trauma such as acute anoxia, a sudden shortage of nutrients, or extreme physical or chemical injury.
The energy failure or drastic decrease in cellular ATP and glucose level occur due to rapid decrease in glucose uptake after ischemia. The decreased ATP levels affect the activity of Na+–K+ ATPase, which consumes up to 70% of cellular ATP. The rise in cellular Na+ due to a decreased activity of Na+–K+ ATPase, causes Ca2+ influx through a Na+–Ca2+ exchanger and Ca2+–Mg2+ ATPase. The increase in intracellular Na+,K+ and Ca2+ causes a rapid influx of water from the extracellular compartment to cell. The cell swells as they take up water (Rathmell & Thompson, 1999) termed cytotoxic edema. Cytotoxic edema begins approximately 30 min to 1 hr after the ischemic insult. If reperfusion of the ischemic area then takes place, rupture of the plasma membrane cause leakage of macromolecules and water into the extravascular space and consequent inflammatory response, termed vasogenic edema (Bradley, 1987). Vasogenic edema begins to develop after 6 hr. The severity and duration of the ischemia determines whether cells may undergo a rapid “necrotic” death due to lysis, or a slower and controlled deterioration, culminating in “apoptotic” death.
Two pathway of apoptosis
1.Mitochondrial pathway of apoptosis
2.Receptor-mediated pathway of apoptosis
1. Mitochondrial pathway of apoptosis
Figure 2: Mitochondrial pathway of apoptosis
Cerebral ischemia and reperfusion generate ROS within mitochondria, which then signal the release of cytochrome c from mitochondria to the cytosolic compartment. cytochrome c is a water-soluble peripheral membrane protein of mitochondria and an essential component of the mitochondrial respiratory chain ( Perez-Pinzon et al., 1999)
Cytochrome c interacts with the Apaf-1 and deoxyadenosine triphosphate forming the apoptosome, which leads to activation of caspase-9. Caspase-9, an initiator of the cytochrome-c-dependent caspase cascade, then activates caspase-3 followed by other downstream caspase-2, -6, -8, and –10 (Slee et al., 1999) Caspase-3 activates DNase (CAD) and The downstream caspases cleave many substrate proteins including poly (ADP-ribose) polymerase (PARP) (Chan et al., 1998). Substrate cleavage causes DNA damage and subsequently apoptotic cell death.
The second mitochondria-derived activator of caspase (Smac), is also released by apoptotic stimuli and binds IAPs, thereby promoting activation of caspase-3( Chai et al.,2002). The inhibitor-of-apoptosis protein (IAP) family suppresses apoptosis by preventing the activation of procaspases and also by inhibiting the enzymatic activity of active caspases.
The Bcl-2 family proteins play a crucial role in intracellular apoptotic signal transduction by regulating permeability of the mitochondrial permeability transition pore (MPTP), from where cytochrome c is released. (Shi et al., 2001) Among these proteins, Bax, Bcl-XS, Bak, Bid, and Bad are proapoptotic. They eliminate the mitochondrial membrane potential by affecting the PTP and facilitating the release of cytochrome c.
2. Receptor-mediated pathway of apoptosis
Figure 3: Receptor-mediated pathway of apoptosis
The death receptor pathway of apoptosis is initiated by members of the death receptor family, such as the Fas receptor and the tumor necrosis factor (TNF) receptor. In the Fas receptor pathway, the extracellular Fas ligand (FasL) first binds to a receptor and an adaptor molecule, Fas-associated death domain (FADD) protein, then activates procaspase-8 (Hengartner et al., 2000). Subsequently, caspase-8 activates caspase-3, and effector caspase cleaves PARP and activates CAD, leading to DNA damage and cell death. Increased expression of Fas and FasL was observed in the ischemic region after focal cerebral ischemia.
In the middle of this pathway, Caspase-8 is also able to activate one of the Bcl-2 family proteins Bid, and to initiate the mitochondrial pathway of apoptosis. (Li et al., 1998)
Neuronal cell death caused by ischemic injury is known to contain a substantial non-apoptotic component. Such pathway has been initiated by Death receptor (DRs) due to the conditions that are not optimal for apoptosis but suitable for death pathway, which they subsequently described as “necroptosis” (Degterev et al., 2005)
It is established that DR mediated extrinsic pathway of apoptosis proceeds through activation of caspase-8. However, necroptosis although initiated by DR, follow an intermediate route through RIP that serves as a bifurcation point separating necroptosis from other DR-dependent pathway of apoptosis. RIP is a serine/threonine kinase and identified as a Fas-interacting protein. It contains three domains, including a N-terminal kinase domain, an intermediate domain and a C-terminal death domain through which it binds to TRADD (TNF receptor associated death domain), a TNF receptor I associated cytoplasmic adapter protein (TNFRI) and induces apoptosis (Stanger et al., 1995).
4.9. Free radical generation
During ischemia, the hydrolysis of ATP via AMP leads to an accumulation of hypoxanthine. Increased intracellular calcium enhances the conversion of xanthine dehydrogenase (XD) to xanthine oxidase (XO). Upon reperfusion and reintroduction of oxygen, XO may produce superoxide and xanthine from hypoxanthine and oxygen Even more damaging free radicals could conceivably be produced by the metal catalyzed Haber-Weiss reaction as follows
O2- + H2O ----Fe3 ------> O2 + OH-+ OH-
Iron, the transition metal needed to drive this reaction, is present in abundant quantities in bound form in living systems in the form of cytochromes, transferrin, hemoglobin and others. Anaerobic conditions have long been known to release such normally bound iron. Indirect experimental confirmation of the role of free iron in generating free-radical injury has come from a number of studies which have confirmed the presence of free-radical breakdown products such as conjugated dienes [Bromont et al; 1989] and low molecular weight species of iron [Babes CF et al; 1985].
During reperfusion and re-oxygenation, significantly increased levels of several free-radical species that degrade cell and capillary membranes have been postulated:
O2-, OH-, and free lipid radicals (FLRs). O2- may be formed by the previously described actions of XO and/or by release from neutrophils which have been activated by leukotrienes.
Re-oxygenation also restores ATP levels, and this may in turn allow active uptake of calcium by the mitochondria, resulting in massive calcium overload and destruction of the mitochondria [Safer p et al; 1985]All cell types normally produce free radicals and other oxidants but their production and elimination rates are equal and therefore they are not noxious under normal, physiological circumstances. However, several types of environmental stresses and neuronal insults lead to the formation of reactive oxygen and nitrogen species. These reactive species include nitric oxide (NO), superoxide radical anion (O2−), hydrogen peroxide (H2O2), hydroxyl free radical (OH) and Peroxynitrite (ONOO−) (Beckman et al., 1990). During cerebral ischemia, free radicals and other oxidant species causes damage to lipids, DNA and proteins leading to neuronal death. They also responsible for brain edema and breakdown of the blood-brain barrier.
•Superoxide radical anion (O2−)
When supply of oxygen and glucose in the brain is interrupted, a cascade of events takes place, leads to depletion of energy source in the form of ATP. Less ATP production leads to perturbation of the Na+/K+-ATPase, and Ca2+/H+-ATPase pumps andreversal of Na+-Ca2+ transporter (Phan et al., 2002) resulting disrupts ionic gradients across the membranes. This causes an increase in extracellular K+ as well as intracellular Na+, Cl−, and Ca2+ into the cells.
During cerebral ischemia, increase intracellular Ca2+ activates phospholipase A2 (PLA2). PLA2 liberates unsaturated fatty acid arachidonic acid and free radicals via the cyclooxygenase and lipoxygenase pathways. Cyclooxygenase catalyzes the addition of two O2 molecules to arachidonic acid to produce the prostaglandin PGG2, that is rapidly peroxidized to PGH2 with a simultaneous release of superoxide radical anion (Lipton ,1999). Expression of inducible isoform of cyclooxygenase, (COX-2) leads to the eicosanoid accumulation and superoxide radical anion production ( Nakayama et al., 1998).
Other pro-oxidant enzymes that generate superoxide radical anion are xanthine oxidase and NADPH oxidase. During ischemia, the hydrolysis of ATP to AMP leads to an accumulation of hypoxanthine. Increased intracellular calcium enhances the conversion of xanthine dehydrogenase to xanthine oxidase. After reperfusion and reintroduction of oxygen, Xanthine oxidase may produce xanthine and superoxide from Hypoxanthine and oxygen (Lo et al., 2003) On the other hand, the oxidation of NADPH by NADPH oxidase in infiltrated neutrophils in the brain parenchyma after ischemia constitutes an additional source of superoxide radical anion (Lipton ,1999).
The most important source of superoxide radical anion in vivo in normal, healthy aerobic cells is the mitochondrial electron-transport chain. The mitochondrial respiratory chain consists of a series of electron carriers that are arranged spatially according to their redox potentials and organized into four complexes (Darley-Usmar et al., 1994). Complex I (NADH coenxyme Q reductase) and complex II (succinate dehydrogenase) accepts electrons from the Krebs cycle electron carrier NADH and FADH2 and passes them to coenzyme Q (ubiquinone).UQ passes electrons to complex III (cytochrome bc1 complex), which passes them to cytochrome c (cyt c). Cyt c passes electrons to Complex IV (cytochrome c oxidase), which uses the electrons and hydrogen ions to reduce molecular oxygen to water.In the course of the redox reactions, a proton electrochemical potential gradient has been established across the membrane. This proton electrochemical potential gradient used by complex V (ATP synthase) for the synthesis of ATP. Some of the electrons (approximately 2 to 5%) passing through these carriers leak to O2 producing an univalent reduction to give O2- (Chance et al., 1979). This formation of O2− and H2O2 takes place mainly at complex I (NADPH dehydrogenase) and at complex III (ubiquinone-cytochrome b-C1) (Boveris & Chance., 1973),
Reactive oxygen species are also produced as a result of opening the MPT pore. Excessive mitochondrial Ca2+ accumulation after the elevation of intracellular Ca2+ caused by glutamate receptor overactivation open the MPT pore ( Brustovetsky et al., 2002) because Ca2+ binds and activates Ca2+ binding sites on the matrix side of the MPTP. MPT can allow antioxidant molecules to exit mitochondria, reducing the organelles ability to neutralize ROS. MPT also causes the mitochondria to become permeable to molecules smaller than 1.5 kDa and draw water in by increasing the organelle’s osmolar load. This may lead mitochondria to swell and may cause the outer membrane to rupture, releasing cytochrome c. Due to loss of cytochrome c, a important component of electrone transport chain can lead to escape of electrone from chain, which can then reduce the molecules and form free radical (Sato et al, 1993).
•Nitric oxide (NO)
Nitric oxide is a physiological messenger in the central nervous system that is formed from L-arginine and O2 in a reaction catalyzed by the NO synthase (Knowles & Moncada, 1994). The three isoforms of nitric oxide synthase (NOS) have been characterized in brain cells (Knowles & Moncada, 1994).
1.nNOS or NOS I -present in neuron under normal physiological condition
2.eNOS or NOS II -present in endothelium under normal physiological condition
3.iNOS or NOS III - expressed in macrophages, kupffer cells, neutrophils, fibroblast, vascular smooth muscle, endotheliumin in response to pathological stimuli.
The elevation in intracellular Ca2+ after the ischemic insult activates nNOS and produces NO. In parallel, an up-regulation of nNOS mRNA and an increase of nNOS immunoreactivity in neurons have been found (Zhang et al., 1994). 10 min after ischemia, nNOS activity increases and returns to normal after 60 min .After ischemia develops, nNOS activity down-regulated and nNOS-stained neurons are lost. This down-regulation may be due to loss of cytosolic proteins due to plasma membrane disruption and inhibition of nNOS activity by NO itself. (Colasanti et al., 1995). eNOS activity and expression is also up-regulated (Nagafuji et al.,1994).
NO is also synthesized by a Ca2+-independent NOS isoform (iNOS) that is expressed by inflammatory factors such as cytokines and/or lipopolysaccharide (LPS) (Knowles & Moncada.. 1994). Cerebral ischemia is associated with a marked inflammatory reaction that results in the expression and release of several cytokines that activate the expression of iNOS in different cell such as polymorphonuclear neutrophils, astrocytes, vascular cells, in the injured brain (Iadecola et al., 1996) The expression is maximal at 12–48 h after the onset of ischemia
Activation of NF-κB has been required for the expression of iNOS gene (Xie et al., 1994). During ischemia, NF-κB activation occurs due to several stimuli such as cytokines, interferon-γ and especially due to calcium-dependent activation of NF-κB via activation of NMDA receptors by glutamate. (Cardenas et al., 2000). Another possibility is that glutamate leads to the expression of iNOS, by directly activating the transcription factor NF-κB (Guerrini et al.,1995;).
An important source of oxidative stress-mediated brain damage is formation of peroxynitrite, a powerful oxidant that results from the reaction between NO and O2 − and which is known to promote neuronal damage following ischemia (Bolannos & Almeida, 1999)
•Other oxidant species
Several species derived from superoxide radical anion mediate most of its toxicity. First, is its reaction with NO to generate peroxynitrite (Radi et al., 2002). In addition, other reaction products of superoxide radical anion, mainly the hydroxyl radical ( OH), are also very reactive and more likely to mediate toxic effects (Halliwell & Gutteridge, 1984). Formation of OH derives from the Fenton reaction, by which H2O2 formed from O2 − dismutation would react with Fe2+ to yield Fe3+, OH−, and OH. This reaction would be favored by free iron and decreased pH that prevails during and after ischemia. However, this reaction is very slow and therefore superoxide radical anion would be largely metabolized by superoxide dismutase and degraded by NO to form peroxynitrite (Beckman, 1994).
•Free radical and lipid peroxidation
Figure 4: Pathways of ROS formation and lipid peroxidation process
(Valko et al., 2007)
Description of reaction are given below:
Reaction 1: The superoxide anion radical is formed by the process of reduction of molecular oxygen mediated by NAD(P)H oxidases and xanthine oxidase or non-enzymatically by redox-reactive compounds such as the semi-ubiquinone compound of the mitochondrial electron transport chain.
Reaction 2: Superoxide radical is dismutated by the superoxide dismutase (SOD) to hydrogen peroxide.
Reaction 3: Hydrogen peroxide is most efficiently scavenged by the enzyme glutathione peroxidase (GPx) into the water and molecular oxygen using glutathione as electrone donor.
Reaction 4: Some transition metals (e.g. Fe2+, Cu+ and others) can breakdown hydrogen peroxide to the reactive hydroxyl radical (Fenton reaction).
Reaction 5: The hydroxyl radical is react with components of the DNA molecule, damaging both the purine and pyrimidine bases. (Halliwell & Gutteridge, 1999).
Reaction 6: The hydroxyl radical can abstract an electron from polyunsaturated fatty acid (LH) to give rise to a carbon-centred lipid radical (L ).
Reaction 7: The lipid radical (L ) can further interact with molecular oxygen to give a lipid peroxyl radical (LOO ).
Reaction 8: Lipid hydroperoxides can react fast with Fe2+ to form lipid alkoxyl radicals (LO ), or much slower with Fe3+ to form lipid peroxyl radicals (LOO ).
Reaction 9: Lipid alkoxyl radical (LO ) undergoes cyclisation reaction to form a six-membered ring hydroperoxide.
Reaction 10: Six-membered ring hydroperoxide udergoes further reactions (involving β-scission) to from 4-hydroxy-nonenal.
Reaction 11: A peroxyl radical react by cyclisation to produce a cyclic peroxide.
Reaction 12: This radical can then either be reduced to form a hydroperoxide (reaction not shown) or it can undergo a second cyclisation to form a bicyclic peroxide which after coupling to dioxygen and reduction yields a molecule structurally analogous to the endoperoxide.
The side chains of all amino acid residues of proteins, in particular cysteine and methionine residues of proteins are susceptible to oxidation by the action of ROS/RNS . Oxidation of cysteine residues may lead to the reversible formation of mixed disulphides between protein thiol groups (–SH) and low molecular weight thiols. (Dalle-Donne et al., 2005).
Advanced glycation end products (AGEs) is a class of complex products. They are the results of a reaction between carbohydrates and free amino group of proteins. The intermediate products are known as Amadori, Schiff Base and Maillard products, named after the researchers who first described them (Dalle-Donne et al., 2005). Most of the AGEs are very unstable, reactive compounds and the end products are difficult to be completely analysed.
1.Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia—The ischemic penumbra. Stroke; 1981; 12; 723–725.
2.Babes CF Free Radical in cerebral in cerebral ischemia; 1985
3.Baron JC. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc. Dis; 1999; 9; 193–201.
4.Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A; 1990; 87;1620–1624.
5.Beckman S Peroxynitrile versus hydroxyl radical : the role of nitric oxide in superoxide dependent cerebral injury. Ann Sci,1994,738;69-75
6.Blaustain Calcium part in cerebral in cerebral ischemia
7.Bolannos P, Almeida A. Roles of nitric oxide in brain hypoxia-ischemia. Biochim. Biophys. Acta; 1999; 1411; 415–436.
8.Boveris A, Chance b. The mitochondrial generation of hydrogen peroxide. Biochem. J; 1973; 134; 707–716.
9.Bradley WG: Pathophysiologic correlates of signal alterations. In Brant-Zawadzki M, and Norman D, eds: Magnetic resonance imaging of the central nervous system, New York, 1987, Raven Press.
10.Bromant Free Radical in cerebral ischemia ; 1989
11.Brustovetsky N, Brustovetsky T, Jemmerson R, and Dubinsky JM. Calcium induced cytochrome c release from CNS mitochondria is associated with the permeability transition and rupture of the outer membrane. Journal of Neurochemistry; 2002; 80; 207-218.
12.Carafoli, Calcium Role in cerebral ischemia
13.Cardenas A, Moro MA, Hurtado O, Leza JC, Lorenzo P, Castrillo A, Bodelón OG, Boscá L, Lizasoain I. Implication of glutamate in the expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices. J. Neurochem; 2000; 74; 2041–2048.
14.Chan J, Nagayama T, Jin K, Stetler RA, Zhu RL, Graham SH et al. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J Neurosci; 1998; 18; 4914–4928.
15.Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Metab; 2001; 21; 2-14
16.Chan PH, Longar S, Fishman RA. Protective effects of liposome-entrapped superoxide dismutase on posttraumatic brain edema. Ann Neurol; 1987; 21; 540−547.
17.Chance B, Sies H, Boveris A. Hydrogen peroxide metabolism in mammalian organs. Physiol. Rev; 1979; 59; 527–605.
18.Colasanti M, Persichini T, Menegazzi M, Mariotto S, Giordano E, Caldareram CM et al. Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide. J. Biol. Chem; 1995; 270; 26731–26733.
19.Dalle-Donne I, Scaloni A, Giustarini D, Cavarra E, Tell G, Lungarella G et al. Proteins as biomarkers of oxidative/nitrosative stress in diseases: The contribution of redox proteomics, Mass Spectrom. Rev; 2005; 24; 55–99.
20.Darley-Usmar VM, Ragan I, Smith P and Wilson M. The proteins of the mitochondrial inner membrane and their role in oxidative phosphorylation. In: V. Darley-Usmar and A.H.V. Schapira, Editors, Mitochondria: DNA, proteins and disease, Portland Press, London; 1994; 1–25.
21.Degterev A, Huang Z, Boyce Mli Y, Jagtap P, Mizushima N et al,. chemical inhibitor of nonapoptotic cell deathwith therapeutic potential for ischemic brain injury. Nat.chem.. bio; 1; 112-119
22.Del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol; 2000; 10; 95–112.
23.Dijkhuizen RM, Beekwilder JP, van derWorp HB, Berkelbach van der Sprenkel JW, Tulleken KA, Nicolay K. Correlation between tissue depolarizations and damage in focal ischemic rat brain. Brain Res; 1999; 840; 194–205.
24.Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci; 1999; 22; 391–7.
25.Durukan A, Tatlisumak T. Acute ischemic stroke: overview of experimental rodent models, Pathophysiology, and Therapy of focal cerebral ischemia. Pharmacol Biochem Behav; 200714; 132-157.
26.Farber JL, Chien KR, Mittnacht S. The pathogenesis of irreversible cell injury in ischemia. Amer J Pathol; 1981;102; 271-81.
27.Garcia JH, Liu KF, Ho KL. Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. Stroke; 1995; 26; 636–642.
28.Gartshore G, Patterson J, Macrae IM. Influence of ischemia and reperfusion on the course of brain tissue swelling and blood-brain barrier permeability in a rodent model of transient focal cerebral ischemia. Exp Neurol; 1997; 147; 353–60.
29.Guerrini L, Blasi F, Denis-Donini S. Synaptic activation of NF-κB by glutamate in cerebellar granule neurons in vitro. Proc. Natl. Acad. Sci. USA; 1995; 92; 9077–9081.
30.Halliwell B, Gutteridge JMC. Free radicals in biology and medicine (3rd ed.). Oxford University Press; 1999.
31.Halliwell B, Gutteridge MC. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J; 1984; 219; 1–14.
32.Hartings JA, Rolli ML, Lu XC, Tortella FC. Delayed secondary phase of peri-infarct depolarizations after focal cerebral ischemia: relation to infarct growth and neuroprotection. J Neurosci; 2003; 23; 11602–10.
33.Hengartner MO. The biochemistry of apoptosis. Nature; 2000; 407; 770–776.
34.Huang J, Choudhri TF, Winfree, CJ, McTaggart RA, Kiss S, Mocco J, Kim LJ, Protopsaltis TS, Zhang, Y, Pinsky, DJ, Connolly JES. Postischemic cerebrovascular E-selectin expression mediates tissue injury in murine stroke. Stroke; 2000; 31; 3047–3053.
35.Iadecola C, Zhang F, Casey R, Clark HB, Ross ME. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke; 1996; 27; 1373–1380.
36.Knowles & Moncanda ; Nitric Oxide in cerebral ischemia; 1994
37.Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell; 1998; 94; 491–501.
38.Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 1999; 79; 1431–1568.
39.Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci; 2003; 4; 399–415.
40.McIlvoy LH. The effect of hypothermia and hyperthermia on acute brain injury. AACN Clin Issues; 2005; 16; 488–500.
41.Mergenthaler P, Dirnagl U, Meisel A. Pathophysiology of stroke: lessons from animal models. Metab Brain Dis; 2004; 19; 151–67.
42.Nagafuji T, Sugiyama M, Matsui T. Temporal profiles of Ca2+/calmodulin-dependent and -independent nitric oxide synthase activity in the rat brain microvessels following cerebral ischemia. Acta Neurochir. Suppl (Wien); 1994; 60; 285–288.
43.Nakayama M, Uchimura K, Zhu RL. Cyclooxygenase-2 inhibition prevents delayed cell death of CA1 hippocampal neurons following global ischemia. Proc. Natl. Acad. Sci. USA; 1998; 95; 10954–10959.
44.Nedergaard M. intracellular Ca[2+] transients evoked by lactic acid in cultured mammalian neurons. Am. j. physiol., Regul. integr. comp. Physiol; 1995; 37
45.Perez-Pinzon MA, Xu GP, Born J, Lorenzo J, Busto R, Rosenthal R et al. Cytochrome c is released from mitochondria into the cytosol after cerebral anoxia or ischemia. J Cereb Blood Flow Metab; 1999; 19; 39–43.
46.Phan TG, Wright PM, Markus R, Howells DW, Davis SM, Donnan GA. Salvaging the ischaemic penumbra: more than just reperfusion? Clin Exp Pharmacol Physiol; 2002; 29; 1–10.
47.Radi R, Cassina A, Hodara R, Quijano C, Castro L. Peroxynitrite reactions and formation in mitochondria. Free Radic. Biol. Med; 2002; 33; 1451–146
48.Rathmell, JC, Thompson CB. The central effectors of cell death in the immune system. Annu. Rev. Immunol; 1999; 17; 781–828.
49.Safer P. Free Radical in cerebral ischemia; 1985
50.Sato S, Tominaga T, Ohnishi T,Ohnishi ST. EPR spin trapping study of nitric oxide formation during bilateral carotid occlusion in the rat. Biochim. Biophys. Acta; 1993; 1811; 195–197.
51.Shi Y, A structural view of mitochondria-mediated apoptosis. Nat Struct Biol; 2001; 8; 394–401.
52.Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD et al. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol; 1999; 144; 281–292.
53.Stanger BZ, Leder P, Lee TH, Kim E, Seed B. RIP: a novel protein containing a death domain that interacts with Fas/ APO-1 (CD95) in yeast and causes cell death. Cell; 1995; 81; 513–523..
54.Tien M, Aust SD. Comparative aspects of several models of lipid peroxidation systems. In Lipid Peroxides in Biology and Medicine. K. Yagi, ed. New York:Academic Press; 1982; 23-39.
55.Valko M, Leibfritz D, Moncol J, Mark TD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Inter. Jou. Biochem. & cell bio; 2007; 39; 44-84
56.Xie QW, Kashiwabara Y,Nathan C. Role of transcription factor NFκB/Rel in induction of nitric oxide synthase. J. Biol. Chem; 1994; 269; 4705–4708.
57.Zhang ZG, Chopp M, Gautam S, Zaloga C, Zhang RL, Schmidt HH, Pollock JS, Forstermann U. Upregulation of neuronal nitric oxide synthase and mRNA, and selective sparing of nitric oxide synthase-containing neurons after focal cerebral ischemia in rat. Brain Res; 1994; 654; 85–95.